Although MYC is an essential modulator of tumor growth via both tumor–cell intrinsic mechanisms and its influence on the tumor microenvironment, and immune effectors (43, 67), direct targeting of MYC is not feasible (68). The gene discussed is MYC; the disease is neoplasm.